Cita APA

Baum, N., Fliegert, R., Bauche, A., Hambach, J., Menzel, S., Haag, F., . . . Koch-Nolte, F. (2020). Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD(+) Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells. Cancers (Basel).

Citación estilo Chicago

Baum, Natalie, Ralf Fliegert, Andreas Bauche, Julia Hambach, Stephan Menzel, Friedrich Haag, Peter Bannas, y Friedrich Koch-Nolte. "Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but Not the NAD(+) Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells." Cancers (Basel) 2020.

Cita MLA

Baum, Natalie, et al. "Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but Not the NAD(+) Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells." Cancers (Basel) 2020.